Strategic Acquisition ScoutPro Osmolarity System operates under the Bausch + Lomb umbrella, aligning with a major eye care portfolio to broaden reach in dry eye management and OCT/ocular surface diagnostics, presenting a pathway for cross-sell to existing B&L customers.

Dry Eye Focus strong emphasis on tear osmolarity as an objective biomarker positions ScoutPro as a key tool for dry eye specialists and clinics investing in evidence-based diagnostics and treatment optimization.

Growth Traction Recent launches and partnerships, including ScoutPro’s origin from Trukera and distribution collaborations in the UK/Ireland, indicate an expanding global footprint and opportunity to upsell to international ophthalmology networks.

Financial Opportunity With a revenue range of ten to twenty-five million and total funding of fifty-five million, there is funding flexibility to support channel expansion, clinical education programs, and integrated device bundles.

Partnership Potential Existing ecosystem with major distributors and alliance potential with clinics adopting dry eye diagnostics signals opportunities for co-marketing, training, and bundled sales with complementary devices in the ophthalmology space.